Citation

Evans CA, Liu T, Lescarbeau A, Nair SJ, Grenier L, Pradeilles JA, Glenadel Q, Tibbitts T, Rowley AM, DiNitto JP, Brophy EE, O'Hearn EL, Ali JA, Winkler DG, Goldstein SI, O'Hearn P, Martin CM, Hoyt JG, Soglia JR, Cheung C, Pink MM, Proctor JL, Palombella VJ, Tremblay MR, Castro AC.: Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor (IPI-549) as an Immuno-Oncology Clinical Candidate. ACS Med Chem Lett, Volume 7 (9), 2016

Authors

Ali JA, Brophy EE, Castro AC., Cheung C, DiNitto JP, Evans CA, Glenadel Q, Goldstein SI, Grenier L, Hoyt JG, Lescarbeau A, Liu T, Martin CM, Nair SJ, O'Hearn EL, O'Hearn P, Palombella VJ, Pink MM, Pradeilles JA, Proctor JL, Rowley AM, Soglia JR, Tibbitts T, Tremblay MR, Winkler DG

Journal

ACS Med Chem Lett

Year

2016

DOI

10.1021/acsmedchemlett.6b00238

PubMed

27660692

Machine-readable

REST APIRDF